Nucleic Acid Therapeutics
Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.
Journal Title
Nucleic Acid Therapeutics
NUCLEIC ACID THER
ISSN / eISSN
2159-3337 / 2159-3345
Aims and Scope
Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.
Subject Area
BIOCHEMISTRY & MOLECULAR BIOLOGY
CHEMISTRY, MEDICINAL
MEDICINE, RESEARCH & EXPERIMENTAL
CiteScore
7.20
View Trend
CiteScore Ranking
Category | Quartile | Rank |
---|---|---|
Pharmacology, Toxicology and Pharmaceutics - Drug Discovery | Q2 | #42/156 |
Pharmacology, Toxicology and Pharmaceutics - Genetics | Q2 | #88/328 |
Pharmacology, Toxicology and Pharmaceutics - Biochemistry | Q2 | #140/428 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Medicine | Q2 | #62/171 |
Pharmacology, Toxicology and Pharmaceutics - Molecular Biology | Q2 | #152/380 |
Web of Science Core Collection
Science Citation Index Expanded (SCIE) | Social Sciences Citation Index (SSCI) |
---|---|
Indexed | - |
Category (Journal Citation Reports 2023) | Quartile |
---|---|
BIOCHEMISTRY & MOLECULAR BIOLOGY - SCIE | Q2 |
CHEMISTRY, MEDICINAL - SCIE | Q2 |
MEDICINE, RESEARCH & EXPERIMENTAL - SCIE | Q2 |
H-index
61
Country/Area of Publication
UNITED STATES
Publisher
Mary Ann Liebert Inc.
Year Publication Started
2011
Annual Article Volume
41
Open Access
NO
Contact
140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, USA, NY, 10801
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started